Home » Topics » Biomarkers, BioWorld Science

Biomarkers, BioWorld Science
RSS

BioPorto reports technical data of NGAL diagnostic test for acute kidney injury

Nov. 3, 2009

Psynova Neurotech and RBM identify diagnostic biomarkers for schizophrenia

Oct. 27, 2009

Bone formation/resorption biomarkers predict response to Re-186 HEDP therapy in prostate cancer

Oct. 27, 2009

Epigenomics initiates testing of mSEPT9 in plasma samples collected in PRESEPT study

Oct. 13, 2009

Epigenomics launches Epi proColon blood test for early detection of colorectal cancer

Oct. 9, 2009

Quest Diagnostics initiates DNA testing for Plavix response in coronary heart patients

Oct. 9, 2009

New CVDefine biomarker kit for cardiovascular disease available in North America

Oct. 1, 2009

FDA clears D3 FastPoint L-DFATM respiratory virus identification kit

Sep. 18, 2009

Luminex receives 510(k) clearance for new cystic fibrosis test

Sep. 9, 2009

Independent research confirms superiority of midkine combined with conventional cancer markers

Sep. 8, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...